Detalhe da pesquisa
1.
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
N Engl J Med
; 387(2): 132-147, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660812
2.
miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.
Blood
; 137(14): 1905-1919, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751108
3.
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma.
Cancer
; 128(10): 1996-2004, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167125
4.
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.
Br J Haematol
; 196(3): 639-648, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671975
5.
The initial management of multiple myeloma in the era of novel agents: 2021 and beyond.
Br J Haematol
; 193(2): 213-215, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33748954
6.
Mezigdomide-A Novel Cereblon E3 Ligase Modulator under Investigation in Relapsed/Refractory Multiple Myeloma.
Cancers (Basel)
; 16(6)2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539501
7.
Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma.
Cancers (Basel)
; 16(5)2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473381
8.
Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial.
Lancet Haematol
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677302
9.
Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial.
JMIR Res Protoc
; 13: e51368, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466984
10.
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone.
medRxiv
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38699307
11.
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy.
Blood Adv
; 8(1): 251-259, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855718
12.
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma.
Blood Cancer Discov
; 5(3): 146-152, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441243
13.
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast.
Adv Ther
; 40(8): 3291-3303, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328635
14.
Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones.
Kidney Int Rep
; 8(12): 2765-2777, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38106576
15.
Respiratory infections predominate after day 100 following B-cell maturation antigen-directed CAR T-cell therapy.
Blood Adv
; 7(18): 5485-5495, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486599
16.
Selinexor: Targeting a novel pathway in multiple myeloma.
EJHaem
; 4(3): 792-810, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601856
17.
Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs.
Clin Exp Med
; 23(7): 3821-3832, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421589
18.
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma.
Expert Opin Drug Saf
; 22(11): 1049-1071, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37906232
19.
MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology.
Cancer Discov
; 13(2): 348-363, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477267
20.
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
Lancet Haematol
; 10(3): e203-e212, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858677